Genomtec SA

0
WAR:GMT (Poland)  
zł 7.97 (+0.89%) Jan 10
At Loss
P/B:
11.19
Market Cap:
zł 106.20M ($ 25.42M)
Enterprise V:
zł 103.07M ($ 24.67M)
Volume:
9.80K
Avg Vol (2M):
39.92K
Trade In:
Volume:
9.80K
At Loss
Avg Vol (2M):
39.92K

Business Description

Description
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
Name Current Vs Industry Vs History
Cash-To-Debt 2.03
Equity-to-Asset 0.54
Debt-to-Equity 0.32
Debt-to-EBITDA -0.34
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.22
Distress
Grey
Safe
Beneish M-Score 1.23
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 60.49
9-Day RSI 56.13
14-Day RSI 54.49
6-1 Month Momentum % -28.82
12-1 Month Momentum % -23.47

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.39
Quick Ratio 2.39
Cash Ratio 1.77
Days Inventory 20.55
Days Sales Outstanding 405807
Days Payable 349.29

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.5
Shareholder Yield % -10.22

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % -119800
Operating Margin % -1143500
Net Margin % -1157600
FCF Margin % -974300
ROE % -123.94
ROA % -61
ROIC % -88.94
3-Year ROIIC % 19.19
ROC (Joel Greenblatt) % -555.68
ROCE % -80.21

Financials

WAR:GMT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Genomtec SA Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil zł) 0.001
EPS (TTM) (zł) -0.87
Beta 0.81
Volatility % 32.99
14-Day RSI 54.49
14-Day ATR (zł) 0.457519
20-Day SMA (zł) 7.8145
12-1 Month Momentum % -23.47
52-Week Range (zł) 6.5 - 14.4
Shares Outstanding (Mil) 13.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genomtec SA Filings

Filing Date Document Date Form
No Filing Data

Genomtec SA Stock Events

Financials Calendars
Event Date Price(zł)
No Event Data

Genomtec SA Frequently Asked Questions

What is Genomtec SA(WAR:GMT)'s stock price today?
The current price of WAR:GMT is zł7.97. The 52 week high of WAR:GMT is zł14.40 and 52 week low is zł6.50.
When is next earnings date of Genomtec SA(WAR:GMT)?
The next earnings date of Genomtec SA(WAR:GMT) is .
Does Genomtec SA(WAR:GMT) pay dividends? If so, how much?
Genomtec SA(WAR:GMT) does not pay dividend.

Press Release

Subject Date
No Press Release